Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Account Payables (2023 - 2025)

Fractyl Health's Change in Account Payables history spans 3 years, with the latest figure at $318000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 78.87% year-over-year to $318000.0, compared with a TTM value of -$1.7 million through Dec 2025, down 162.03%, and an annual FY2025 reading of -$1.7 million, down 162.03% over the prior year.
  • Change in Account Payables for Q4 2025 was $318000.0 at Fractyl Health, up from -$2.7 million in the prior quarter.
  • The five-year high for Change in Account Payables was $2.4 million in Q2 2025, with the low at -$2.7 million in Q3 2025.
  • Average Change in Account Payables over 3 years is $49416.7, with a median of $3500.0 recorded in 2023.
  • Year-over-year, Change in Account Payables skyrocketed 1854.55% in 2024 and then tumbled 652.12% in 2025.
  • Tracing GUTS's Change in Account Payables over 3 years: stood at $77000.0 in 2023, then skyrocketed by 1854.55% to $1.5 million in 2024, then tumbled by 78.87% to $318000.0 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Change in Account Payables are $318000.0 (Q4 2025), -$2.7 million (Q3 2025), and $2.4 million (Q2 2025).